Steward Partners Investment Advisory LLC Has $6.62 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Steward Partners Investment Advisory LLC reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 2.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 72,827 shares of the company’s stock after selling 2,033 shares during the period. Steward Partners Investment Advisory LLC’s holdings in Colgate-Palmolive were worth $6,621,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. Chicago Partners Investment Group LLC raised its holdings in shares of Colgate-Palmolive by 16.2% during the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock worth $591,000 after acquiring an additional 943 shares during the period. Peak Financial Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $1,315,000. Gordian Advisors LLC bought a new stake in shares of Colgate-Palmolive in the third quarter valued at about $602,000. Carrera Capital Advisors lifted its holdings in shares of Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after purchasing an additional 7,353 shares in the last quarter. Finally, Fiduciary Alliance LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter worth about $4,066,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.9 %

CL opened at $91.87 on Thursday. The stock’s fifty day simple moving average is $88.72 and its 200 day simple moving average is $95.27. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The stock has a market cap of $74.56 billion, a PE ratio of 26.10, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the firm earned $0.87 EPS. As a group, research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.18%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Analysts Set New Price Targets

CL has been the topic of several research reports. Royal Bank of Canada restated a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Barclays cut their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Morgan Stanley decreased their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. TD Cowen cut their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Finally, Raymond James restated an “outperform” rating and issued a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average price target of $101.61.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.